The Sentinel

Human Rights Action :: Humanitarian Response :: Health :: Education :: Heritage Stewardship ::
Sustainable Development
__________________________________________________
Week ending 25 April 2020 :: Number 313

This weekly digest is intended to aggregate and distill key content from a broad spectrum of practice domains and organization types including key agencies/IGOs, NGOs, governments, academic and research institutions, consortia and collaborations, foundations, and commercial organizations. We also monitor a spectrum of peer-reviewed journals and general media channels. The Sentinel’s geographic scope is global/regional but selected country-level content is included. We recognize that this spectrum/scope yields an indicative and not an exhaustive product. Comments and suggestions should be directed to:

David R. Curry
Editor
GE2P2 Global Foundation – Governance, Evidence, Ethics, Policy, Practice
david.r.curry@ge2p2center.net

PDF:The Sentinel_ period ending 25 Apr 2020

Contents
:: Week in Review  [See selected posts just below]
:: Key Agency/IGO/Governments Watch – Selected Updates from 30+ entities   [see PDF]
:: INGO/Consortia/Joint Initiatives Watch – Media Releases, Major Initiatives, Research:: Foundation/Major Donor Watch -Selected Updates
:: Journal Watch – Key articles a

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19

COVID-19: Global Commitments/Equity/Access

Global leaders unite to ensure everyone everywhere can access new vaccines, tests and treatments for COVID-19
Unprecedented gathering of heads of government, institutions and industry cements commitment to accelerate development and delivery for all populations
24 April 2020 News release
GENEVA – Heads of state and global health leaders today made an unprecedented commitment to work together [see below] to accelerate the development and production of new vaccines, tests and treatments for COVID-19 and assure equitable access worldwide.

…leaders came together at a virtual event, co-hosted by the World Health Organization, the President of France, the President of the European Commission, and the Bill & Melinda Gates Foundation. The event was joined by the UN Secretary General, the AU Commission Chairperson, the G20 President, heads of state of France, South Africa, Germany, Vietnam, Costa Rica, Italy, Rwanda, Norway, Spain, Malaysia and the UK (represented by the First Secretary of State).

Health leaders from the Coalition for Epidemic Preparedness Innovations (CEPI), GAVI-the Vaccine Alliance, the Global Fund, UNITAID, the Wellcome Trust, the International Red Cross and Red Crescent Movement (IFRC), the International Federation of Pharmaceutical Manufacturers (IFPMA), the Developing Countries Vaccine Manufacturers’ Network (DCVMN), and the International Generic and Biosimilar Medicines Association (IGBA) committed to come together, guided by a common vision of a planet protected from human suffering and the devastating social and economic consequences of COVID-19, to launch this groundbreaking collaboration. They are joined by two Special Envoys: Ngozi Okonjo-Iweala, Gavi Board Chair and Sir Andrew Witty, former CEO of GlaxoSmithKline…

.

Commitment and call to action: Global collaboration to accelerate new COVID-19 health technologies
A Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines
24 April 2020
Statement
Our Vision and Mission
Grounded in a vision of a planet protected from human suffering and the devastating social and economic consequences of COVID-19, we, an initial group of global health actors (BMGF, CEPI, Gavi, Global Fund, UNITAID, Wellcome Trust, WHO) and private sector partners and other stakeholders, are launching a landmark, global and time-limited collaboration to accelerate the development, production and equitable global access to new COVID-19 essential health technologies.

We know that as long as anyone is at risk from this virus, the entire world is at risk – every single person on the planet needs to be protected from this disease.

We agree that alongside evidence-based public health measures, innovative COVID-19 diagnostics, therapeutics and vaccines are needed – in record time and at record scale and access – to save millions of lives and countless trillions of dollars, and to return the world to a sense of ‘normalcy’.

We recognize the significant amount of critical work, investment and initiatives already ongoing around the world to expedite the development and deployment of innovative COVID-19 related products and interventions.

We appreciate that while development and deployment of innovative products is essential, it will not be enough. We must simultaneously and urgently accelerate the strengthening of sustainable health systems and capacities to enable delivery of the new COVID-19 tools to those who need them and to mitigate the knock-on impact on other diseases.

We remember lessons from the past, which have shown that even when effective tools are available to the world, too often some are protected, while others are not. This inequity is unacceptable – all tools to address COVID-19 must be available to all. In the fight against COVID-19, no one should be left behind.

We understand we cannot do this alone, and that we need to work together in unprecedented and inclusive partnership with all stakeholders – political leaders, public and private sector partners, civil society, academia, and all other stakeholders across society – jointly leveraging our comparative strengths and respective voices to drive towards collective solutions, an accelerated path, and access for all. We are stronger, faster and more effective working together.

Our Mission is not only accelerated development and availability of new COVID-19 tools – it is to accelerate equitable global access to safe, quality, effective, and affordable COVID-19 diagnostics, therapeutics and vaccines, and thus to ensure that in the fight against COVID-19, no one is left behind.

Our Commitment
[1] We commit to the shared aim of equitable global access to innovative tools for COVID-19 for all.
[2] We commit to an unprecedented level of partnership – proactively engaging stakeholders, aligning and coordinating efforts, building on existing collaborations, collectively devising solutions, and grounding our partnership in transparency, and science.
[3] We commit to create a strong unified voice to maximize impact, recognizing this is not about singular decision-making authority, but rather collective problem-solving, interconnectedness and inclusivity, where all stakeholders can connect and benefit from the expertise, knowledge and activities of this shared action-oriented platform.
[4] We commit to build on past experiences towards achieving this objective, including ensuring that every activity we undertake is executed through the lens of equitable global access, and that the voices of the communities most affected are heard.
[5] We commit to be accountable to the world, to communities, and to one another. We are coming together in the spirit of solidarity, and in the service of humanity, to achieve our mission and vision.

Our Call
We ask the global community and political leaders to support this landmark collaboration, and for donors to provide the necessary resources to accelerate achievement of the objectives of this global collaboration, capitalizing on the opportunity provided by the rolling pledging campaign that will start on 4 May 2020.

Over 13 million children did not receive any vaccines at all even before COVID-19 disrupted global immunization – UNICEF

Over 13 million children did not receive any vaccines at all even before COVID-19 disrupted global immunization – UNICEF
NEW YORK, 25 April 2020 – As the world waits desperately for a vaccine, the COVID-19 pandemic is continuing to surge across the globe. Millions of children are in danger of missing life-saving vaccines against measles, diphtheria and polio due to disruptions in immunization services. At last count, most countries had suspended mass polio campaigns and 25 countries had postponed mass measles campaigns, as per recommended guidance.

Even before the COVID-19 pandemic, measles, polio and other vaccines were out of reach for 20 million children below the age of one every year. Over 13 million children below the age of one globally did not receive any vaccines at all in 2018, many of whom live in countries with weak health systems. Given the current disruptions, this could create pathways to disastrous outbreaks in 2020 and well beyond.

“The stakes have never been higher. As COVID-19 continues to spread globally, our life-saving work to provide children with vaccines is critical,” said Robin Nandy, UNICEF Principal Adviser and Chief of Immunization. “With disruptions in immunization services due to the COVID-19 pandemic, the fates of millions of young lives hang in the balance.”

An estimated 182 million children missed out on the first dose of the measles vaccine between 2010 and 2018, or 20.3 million children a year on average, according to a UNICEF analysis. This is because the global coverage of the first dose of measles stands only at 86 per cent, well below the 95 per cent needed to prevent measles outbreaks.

Widening pockets of unvaccinated children led to alarming measles outbreaks in 2019, including in high-income countries like the US, UK and France.

Among low-income countries, the gaps in measles coverage before COVID-19 were already alarming. Between 2010 and 2018, Ethiopia had the highest number of children under one year of age who missed out on the first dose of measles, at nearly 10.9 million. It was followed by the Democratic Republic of the Congo (6.2 million), Afghanistan (3.8 million), Chad, Madagascar and Uganda with about 2.7 million each.

Beyond measles, the immunization gaps were already quite dire, according to new regional profiles developed by UNICEF. In Africa, more children have missed out on vaccines over the past years due to rising number of births and a stagnation in immunization services. For example, in West and Central Africa, coverage has stagnated at 70 per cent for DTP3 – which is the lowest among all regions – at 70 per cent for polio, and at 71 per cent for measles. This has led to repeated outbreaks of measles and polio in countries such as the Democratic Republic of the Congo. Meanwhile, in South Asia, an estimated 3.2 million children did not receive any vaccines in 2018. In Eastern and Southern Africa, the number of unvaccinated children has remained almost the same for the last decade, at around 2 million. All regions are now also battling COVID-19 outbreaks.

UNICEF is sending critical vaccine supplies to immunize children, where possible, in areas with outbreaks and to replenish their routine supplies.In the Democratic Republic of the Congo, for example, UNICEF is supporting the Government with vaccine supplies and protective equipment to continue immunization activities in North Kivu province, where over 3,000 cases of measles were reported since January 1. And in Uganda, UNICEF procured 3,842,000 doses of bivalent oral polio vaccine (bOPV) to immunize 900,000 children below the age of one year. Children receive three doses of the polio vaccine before they celebrate their first birthday.

As the world races to develop and test a new COVID-19 vaccine, UNICEF and partners in the Measles & Rubella Initiative and Gavi, the Vaccine Alliance are calling on governments and donors to:
:: Sustain immunization services while keeping health workers and communities safe;
:: Start planning to ramp up vaccinations for every missed child when the pandemic ends;
: Fully replenish Gavi, as the alliance supports immunization programmes in the future;
:: Ensure that when the COVID-19 vaccine is available, it reaches those most in need.

“Children missing out now on vaccines must not go their whole lives without protection from disease,” said Dr. Seth Berkley, CEO, Gavi, the Vaccine Alliance “The legacy of COVID-19 must not include the global resurgence of other killers like measles and polio.”

COVID-19: Fake Medicines; Trade Restrictions for Medical Supplies/Food

COVID-19: Fake Medicines

The global response to the coronavirus pandemic must not be undermined by bribery
In the face of the coronavirus outbreak, the OECD Working Group on Bribery reaffirms its collective commitment to fight foreign bribery under the Anti-Bribery Convention.
22-April-2020
Recent seizures of fake medical supplies being marketed as protection against Covid-19 underscore the need to address a growing international trade in counterfeit pharmaceuticals that is costing billions of euros a year and putting lives at risk, according to the OECD and the EU’s Intellectual Property Office.

A joint report, Trade in Counterfeit Pharmaceutical Products, and an accompanying brief on links with the Covid-19 crisis, says the trafficking and sale of fake or defective medicines is enriching criminal groups and endangering health while draining away vital industry and tax revenues. Analysis of customs seizures over 2014-16 finds that trade in counterfeit pharmaceuticals was worth EUR 4 billion in 2016. That figure excludes fake medicines produced and consumed domestically and shipments of pharmaceuticals that are stolen in transit and rerouted for sale in a different market or country.

“The sale of counterfeit and defective pharmaceuticals is a despicable crime, and the discovery of fake medical supplies related to Covid-19 just as the world pulls together to fight this pandemic makes this global challenge all the more acute and urgent,” said OECD Secretary-General Angel Gurría. “We hope the evidence we have gathered on the value, scope and trends of this illicit trade will help lead to rapid solutions to combat this scourge.”
Interpol recently reported a rise in fake medical products related to Covid-19. Seizures of fake Covid-19 tests, facemasks and hand sanitizers have been reported by customs authorities such as the US Customs and Border Protection, and the World Customs Organisation.

The OECD-EUIPO report finds that most of the counterfeit drugs seized over 2014-16 were fake antibiotics, male impotence pills, painkillers and medication for malaria, diabetes, epilepsy, heart disease, HIV/AIDS, cancers, high blood pressure and allergies. The vast majority contain incorrect proportions of active ingredients, meaning they are unlikely to work. Many contain undeclared substances that can pose serious health risks. Forensic tests of suspect samples show that in 90% of cases, counterfeit medicines can harm patients.

Strong global demand, high profit margins and a low risk of detection make pharmaceuticals especially vulnerable to counterfeiting. Criminal groups may traffic medicines made with substandard ingredients or steal legitimate pharmaceuticals destined for hospitals to sell on the street at cut prices, often storing them in poor conditions that reduce their effectiveness.

Read the report: Trade in Counterfeit Pharmaceutical Products

::::::
::::::

COVID-19: Medical Supplies/Food and Trade Restrictions

WTO and IMF heads call for lifting trade restrictions on medical supplies and food
April 24, 2020
As our members grapple with their response to the global health and economic crisis, we call for more attention to the role of open trade policies in defeating the virus, restoring jobs, and reinvigorating economic growth. In particular, we are concerned by supply disruptions from the growing use of export restrictions and other actions that limit trade of key medical supplies and food.

Trade has made cutting-edge medical products available throughout the world at competitive prices. Last year global imports of crucial goods needed in the fight against COVID-19, such as face masks and gloves, hand soap and sanitizer, protective gear, oxygen masks, ventilators, and pulse oximeters, totalled nearly $300 billion. Recognizing the importance of this trade, governments have taken dozens of measures to facilitate imports of COVID-related medical products—cutting import duties, curbing customs-clearance processes, and streamlining licensing and approval requirements.

We welcome these actions. Accelerating imports of critical medical supplies translates into saving lives and livelihoods. Similar attention should be paid to facilitating exports of key items like drugs, protective gear, and ventilators. Anticipating governments’ need to address domestic crises, World Trade Organization (WTO) rules allow for temporary export restrictions “applied to prevent or relieve critical shortages” in the exporting country. We urge governments to exercise caution when implementing such measures in the present circumstances.

This time is different
Taken collectively, export restrictions can be dangerously counterproductive. What makes sense in an isolated emergency can be severely damaging in a global crisis. Such measures disrupt supply chains, depress production, and misdirect scarce, critical products and workers away from where they are most needed. Other governments counter with their own restrictions. The result is to prolong and exacerbate the health and economic crisis—with the most serious effects likely on the poorer and more vulnerable countries.

To ramp up the production of medical supplies, it is essential to build on existing cross-border production and distribution networks.

Trade finance and food items
We are also concerned by the decline in the supply of trade finance. Adequate trade finance is important to ensure that imports of food and essential medical equipment reach the economies where they are most needed. Our institutions are tracking developments and engaging with key suppliers of trade finance.

In addition to restrictions on medical goods, curbs on some food items are starting to appear, despite strong supply. The experience in the global financial crisis showed that food export restrictions multiply rapidly across countries and lead to ever greater uncertainties and price increases. We are also concerned that if critical agricultural workers are not able to move to where the harvest is, crops could rot in the fields. Where new cropping seasons are starting, planting could be hampered, lowering both domestic and international supplies and increasing food insecurity. We urge governments to address these challenges in a safe and proportionate manner.

Cooperative effort needed
Amid the unfolding global financial crisis, global economic leaders in 2008 jointly committed to refrain for a year from new import, export, and investment restrictions. This pledge helped to avoid widespread trade restrictions that would have worsened the crisis and delayed recovery—just as trade restrictions deepened and prolonged the Great Depression of the 1930’s.

A similarly bold step is needed today. We call on governments to refrain from imposing or intensifying export and other trade restrictions and to work to promptly remove those put in place since the start of the year. The WTO and the G20 offer two forums for global policy coordination on these important matters.

History has taught us that keeping markets open helps everyone – especially the world’s poorest people. Let’s act on the lessons we have learned.

COVID-19: Food Security/Nutrition

COVID-19: Food Security/Nutrition

Global Report on Food Crises – Joint Analysis for Better Decisions
Food Security Information Network
April 2020 :: 240 pages
PDF: https://reliefweb.int/sites/reliefweb.int/files/resources/WFP-0000114546.pdf
GRFC 2020 in brief
The data and the analyses in this report were prepared before the global crisis of the COVID-19 pandemic and do not account for its impact on vulnerable people in food-crisis situations.

The Global Report on Food Crises (GRFC) 2020 is the result of a joint, consensus-based assessment of acute food insecurity situations around the world by 16 partner organizations.

At 135 million, the number of people in Crisis or worse (IPC/CH Phase 3 or above) in 2019 was the highest in the four years of the GRFC’s existence. This increase also reflected the inclusion of additional countries and areas within some countries.

When comparing the 50 countries that were in both the 2019 and the 2020 reports, the population in Crisis or worse (IPC/CH Phase 3 or above) rose from 112 to 123 million. This reflected worsening acute food insecurity in key conflict-driven crises, notably the Democratic Republic of the Congo and South Sudan and the growing severity of drought and economic shocks as drivers in countries such as Haiti, Pakistan and Zimbabwe.

Around 183 million people in 47 countries were classified in Stressed (IPC/CH Phase 2) conditions, at risk of slipping into Crisis or worse (IPC/CH Phase 3 or above) if confronted by an additional shock or stressor.

An estimated 75 million stunted children were living in the 55 food-crisis countries analysed. These children have limited access to sufficient dietary energy, nutritionally diverse diets, clean drinking water, sanitation and health care, which weakens their health and nutrition status, with dire consequences for their development and long-term productivity.

Drivers of acute food insecurity
Conflict/insecurity was still the main driver of food crises in 2019, but weather extremes and economic shocks became increasingly significant. Over half of the 77 million acutely foodinsecure people in countries where conflict was identified as the primary driver were in the Middle East and Asia. Regional crises continued to see high levels of acute food insecurity, particularly in the Lake Chad Basin and Central Sahel.

Africa had the largest numbers of acutely food-insecure people in need of assistance in countries badly affected by weather events, particularly in the Horn of Africa and Southern Africa, followed by Central America and Pakistan.

In East Africa, armed conflicts, intercommunal violence and other localized tensions continued to affect peace and security, particularly in South Sudan, and continued to maintain large refugee populations in neighbouring countries, such as Uganda.

The report reflects the growing influence of economic crises on acute food insecurity levels, particularly in the Bolivarian Republic of Venezuela, Zimbabwe, Haiti and the Sudan.

An estimated 79 million people remained displaced globally as of mid-2019 – 44 million of them internally displaced and 20 million were refugees under UNHCR’s mandate. More than half of these refugees were hosted in countries with high numbers of acutely food-insecure people. In countries where funding constraints have reduced assistance in refugee camps, refugees’ food security was severely threatened.

-Short-term outlook for 2020
The acute food insecurity forecasts for 2020 were produced before COVID-19 became a pandemic and do not account for its likely impact in food crisis countries.

The combined effects of conflict, macroeconomic crisis, climaterelated shocks and crop pests, including fall armyworm and desert locusts, were likely to ensure that Yemen remained the world’s worst food crisis.

In East Africa, abundant seasonal rains benefitted crops and rangelands, but fostered a severe desert locust outbreak that will likely aggravate acute food insecurity in complex and fragile contexts.

Protracted conflicts will either maintain or increase acute food insecurity levels in parts of Central Africa. In Southern Africa, post-harvest improvements are likely to be short-lived as poor rains, high food prices and unresolved political and economic instability could worsen acute food insecurity levels. Increasing violence, displacements and disrupted agriculture and trade in tandem with adverse climate in West Africa and Sahel countries will worsen acute food insecurity conditions in many areas.

Violent conflict and currency depreciation will drive alarming rates of acute food insecurity and acute malnutrition levels across the most troubled areas of the Middle East and Asia.

In Latin America and the Caribbean, sociopolitical crises, weather extremes, lack of employment and high food prices are likely to lead to deteriorating acute food insecurity in some countries.

The drivers of food crises, as well as lack of access to dietary energy and diversity, safe water, sanitation and health care will continue to create high levels of child malnutrition, while COVID-19 is likely to overburden health systems.

The pandemic may well devastate livelihoods and food security, especially in fragile contexts and particularly for the most vulnerable people working in the informal agricultural and nonagricultural sectors. A global recession will majorly disrupt food supply chains.

::::::

Joint Statement on COVID-19 Impacts on Food Security and Nutrition
FAO, IFAD, WFP and the World Bank on the occasion of the Extraordinary G20 Agriculture Minister’s Meeting
WASHINGTON, April 21, 2020— The COVID-19 pandemic has led to dramatic loss of human life across the world and presents an unprecedented challenge with deep social and economic consequences, including compromising food security and nutrition. Responses need to be well coordinated across the world, including by the G20 and beyond, to limit impacts, end the pandemic, and prevent its recurrence.

The pandemic is already affecting the entire food system. Restrictions on movement within and across countries can hinder food-related logistic services, disrupt entire food supply chains and affect the availability of food. Impacts on the movement of agricultural labor and on the supply of inputs will soon pose critical challenges to food production, thus jeopardizing food security for all people, and hit especially hard people living in the poorest countries.

Agriculture and its food-related logistic services should be considered as essential. Increased efforts are needed to ensure that food value chains function well and promote the production and availability of diversified, safe and nutritious food for all. In doing this, it is necessary to give precedence to the health of consumers and workers, adhering to safety measures, such as testing, physical distancing and other hygienic practices.

Currently, the world food market is well supplied and all countries, particularly those with prominent trade shares, need to ensure that it remains a stable, transparent and reliable source of food. During the 2007-08 food price crisis, panic-driven policy responses, such as export bans and rapid escalation in food stock procurement through imports exacerbated market disruptions.

While food supplies were tighter because of weather shocks globally in 2007-08, this behavior stretches the balance between global food supply and demand, increasing price volatility and ultimately contributing to it. These immediate impacts proved extremely damaging for low-income food-import dependent countries, and to the efforts of humanitarian organizations to procure supplies.
Countries need to work together to strengthen cooperation during this pandemic that is affecting all regions of the world. It is important to ensure that policies, such as short-term measures to restrict trade, do not distort global markets.

Collective action is needed to ensure that markets are well-functioning, and that timely and reliable information on market fundamentals is available to all. This will reduce uncertainty and allow producers, consumers, traders and processors to make informed production and trade decisions and contain panic behavior in global markets.

The Agricultural Market Information System – a G20 initiative that combines the expertise of ten International Organizations with the information provided by countries with a high share in world food trade – is monitoring world supply and price developments.

The devastating economic impacts of COVID-19 reinforce the need for investments that prevent future outbreaks of such infectious diseases, recognizing the interconnections between people, animals, plants and their shared environment – the One Health approach. Continued attention is necessary strengthen the resilience of food systems to such disease outbreaks but also to other shocks.

As the pandemic slows down economies, access to food will be negatively affected by income reductions and loss of employment as well as availability of food in local markets. Efforts should focus on supporting access to food for the poor and the vulnerable and those whose income is most affected. Implementing adequate social protection measures, such as cash transfers, and investing in early recovery efforts in response to COVID-19 is critical to saving both lives and livelihoods. Ensuring that these measures reach everyone will be key to avoid further spread of poverty and hunger.

Countries with existing humanitarian crises are particularly exposed to the effects of the pandemic. Its effects could be even stronger in those countries that are already facing exceptional emergencies with direct consequences for agriculture including due to ongoing or emerging conflict and climate shocks or desert locust outbreaks.

The pandemic is likely to have significant repercussions on the delivery of humanitarian and recovery assistance. Maintaining ongoing humanitarian assistance to vulnerable groups and adapting to potential COVID-19 impacts is critical. Investment is needed to accelerate recovery efforts and build resilience of vulnerable populations, coordinating our efforts with all partners including with the UN framework for the immediate socio-economic response to COVID-19.

Decisive collective action is needed now to ensure that this pandemic does not threaten food security and nutrition, and to improve resilience to future shocks. On this, we highlight the 2021 Food Systems Summit as an opportunity to drive transformative action and contribute to the UN Decade of Action to deliver the SDGs by 2030.

Coronavirus: Commission launches data sharing platform for researchers

COVID-19: R&D

Coronavirus: Commission launches data sharing platform for researchers
Press release 20 April 2020
Today, the European Commission together with several partners launched a European COVID-19 Data Platform to enable the rapid collection and sharing of available research data. The platform, part of the ERAvsCorona Action Plan, marks another milestone in the EU’s efforts to support researchers in Europe and around the world in the fight against the coronavirus outbreak.

Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said: “Launching the European COVID-19 Data Platform is an important concrete measure for stronger cooperation in fighting the coronavirus. Building on our dedicated support for open science and open access over the years, now is the time to step up our efforts and stand united with our researchers. Through our joint efforts, we will better understand, diagnose and eventually overpower the pandemic.”

The new platform will provide an open, trusted, and scalable European and global environment where researchers can store and share datasets, such as DNA sequences, protein structures, data from pre-clinical research and clinical trials, as well as epidemiological data. It is the result of a joint effort by the European Commission, the European Bioinformatics Institute of the European Molecular Biology Laboratory (EMBL-EBI), the Elixir infrastructure and the COMPARE project, as well as the EU Member States and other partners.

Rapid open sharing of data greatly accelerates research and discovery, allowing for an effective response to the coronavirus emergency. The European COVID-19 Data Platform is in line with the principles established in the Statement on Data Sharing in Public Health Emergency and accentuates the Commission’s commitment to open research data and Open Science, which aims at making science more efficient, reliable, and responsive to societal challenges. In this context, the platform is also a priority pilot, aimed at realising the objectives of the European Open Science Cloud (EOSC), and builds upon established networks between EMBL-EBI and national public health data infrastructures.

ERAvsCorona Action Plan
On 7 April 2020, research and innovation Ministers from all 27 EU Member States supported 10 priority actions of the ERAvsCorona Action Plan. Building on the overall objectives and the tools of the European Research Area (ERA), the Action Plan covers short-term actions based on close coordination, cooperation, data sharing and joint funding efforts between the Commission and the Member States. It is centred around the key principles of the European Research Area, which will now be used to achieve towards their maximum effect to help researchers and EU Member States succeed in their fight against the coronavirus pandemic…

EMERGENCIES – Coronavirus [COVID-19]

EMERGENCIES

Coronavirus [COVID-19]
Public Health Emergency of International Concern (PHEIC)

Editor’s Note:
We certainly recognize the velocity of global developments in the COVID-19 pandemic. While we have concentrated the most current key reports just below, COVID-19 announcements, analysis and commentary will be found throughout this issue, in all sections.
Beyond the considerable continuing coverage in the global general media, the WHO’s authoritative guidance is available here:
:: Daily WHO situation reports here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
:: WHO Coronavirus disease (COVID-2019) daily press briefings here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/press-briefings

Situation report – 96 [WHO]

Novel Coronavirus (COVID-19)
25 April 2020
[Excerpts]
SITUATION IN NUMBERS
Globally
2 719 897 confirmed (93 716)
187 705 deaths (5767)

European Region
1 314 666 confirmed (30 450)
119 463 deaths (2940)

Region of the Americas
1 047 508 confirmed (52 138)
53 103 deaths (2520)

Eastern Mediterranean Region
154 971 confirmed (5676)
6750 deaths (142)

Western Pacific Region
141 470 confirmed (1688)
5906 deaths (37)

South-East Asia Region
41 073 confirmed (2501)
1658 deaths (104)

African Region
19 497 confirmed (1263)
812 deaths (24)

WHO RISK ASSESSMENT
Global Level – Very High

HIGHLIGHTS
:: WHO, together with heads of state, global health leaders, private sector partners and other stakeholders launched the Access To COVID-19 Tools (ACT) Accelerator, a global collaboration to accelerate the development, production and equitable access to new COVID-19 diagnostics, therapeutics and vaccines. More information including the WHO Director General’s opening remarks, full list of participants, and the group’s statement, are available.

:: Although some governments have suggested that the detection of antibodies to SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an “immunity passport” or “risk-free certificate”, there is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection. More information is available here.

:: WHO has seen a dramatic increase in the number of cyber-attacks directed at its staff, and email scams targeting the public. WHO asks the public to remain vigilant against fraudulent emails and recommends using reliable sources to obtain factual information about COVID-19 and other health issues. More information is available here.

::::::

“Immunity passports” in the context of COVID-19
WHO Scientific Briefs
24 April 2020
WHO has published guidance on adjusting public health and social measures for the next phase of the COVID-19 response.1 Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an “immunity passport” or “risk-free certificate” that would enable individuals to travel or to return to work assuming that they are protected against re-infection. There is currently no evidence that people who have recovered from COVID-19 and have antibodies are protected from a second infection.

The measurement of antibodies specific to COVID-19
The development of immunity to a pathogen through natural infection is a multi-step process that typically takes place over 1-2 weeks. The body responds to a viral infection immediately with a non-specific innate response in which macrophages, neutrophils, and dendritic cells slow the progress of virus and may even prevent it from causing symptoms. This non-specific response is followed by an adaptive response where the body makes antibodies that specifically bind to the virus. These antibodies are proteins called immunoglobulins. The body also makes T-cells that recognize and eliminate other cells infected with the virus. This is called cellular immunity. This combined adaptive response may clear the virus from the body, and if the response is strong enough, may prevent progression to severe illness or re-infection by the same virus. This process is often measured by the presence of antibodies in blood.

WHO continues to review the evidence on antibody responses to SARS-CoV-2 infection.2-17 Most of these studies show that people who have recovered from infection have antibodies to the virus. However, some of these people have very low levels of neutralizing antibodies in their blood,4 suggesting that cellular immunity may also be critical for recovery. As of 24 April 2020, no study has evaluated whether the presence of antibodies to SARS-CoV-2 confers immunity to subsequent infection by this virus in humans.

Laboratory tests that detect antibodies to SARS-CoV-2 in people, including rapid immunodiagnostic tests, need further validation to determine their accuracy and reliability. Inaccurate immunodiagnostic tests may falsely categorize people in two ways. The first is that they may falsely label people who have been infected as negative, and the second is that people who have not been infected are falsely labelled as positive. Both errors have serious consequences and will affect control efforts. These tests also need to accurately distinguish between past infections from SARS-CoV-2 and those caused by the known set of six human coronaviruses. Four of these viruses cause the common cold and circulate widely. The remaining two are the viruses that cause Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome. People infected by any one of these viruses may produce antibodies that cross-react with antibodies produced in response to infection with SARS-CoV-2.

Many countries are now testing for SARS-CoV-2 antibodies at the population level or in specific groups, such as health workers, close contacts of known cases, or within households.21 WHO supports these studies, as they are critical for understanding the extent of – and risk factors associated with – infection.  These studies will provide data on the percentage of people with detectable COVID-19 antibodies, but most are not designed to determine whether those people are immune to secondary infections.

Other considerations
At this point in the pandemic, there is not enough evidence about the effectiveness of antibody-mediated immunity to guarantee the accuracy of an “immunity passport” or “risk-free certificate.” People who assume that they are immune to a second infection because they have received a positive test result may ignore public health advice. The use of such certificates may therefore increase the risks of continued transmission. As new evidence becomes available, WHO will update this scientific brief.
Citations/References at title link above

::::::
::::::

Emergencies – Ebola

Emergencies

Ebola – DRC+
Public Health Emergency of International Concern (PHEIC)

Ebola Outbreak in DRC 89: 21 April 2020
[Excerpts]
Situation Update WHO Health Emergencies Programme Page 2
From 13 to 19 April 2020, four new confirmed cases of Ebola virus disease (EVD) were reported in the Democratic Republic of the Congo, all from Beni Health Zone in North Kivu Province. Three out of four cases were registered as contacts, though none were regularly followed by the response team because of insecurity and ongoing challenges with community reticence.
In total, six cases have been reported since 10 April, four of whom have passed away. Currently there is one confirmed case receiving care at an Ebola treatment centre and one who remains in the community; response teams are engaging with the community in order to address this.
Prior to the emergence of this cluster in Beni, the last person confirmed to have EVD tested negative twice and was discharged from a treatment centre on 3 March 2020…
…An urgent injection of US$ 20 million is required to ensure that response teams have the capacity to maintain the appropriate level of operations through to the beginning of May 2020.

…Conclusion
The new confirmed cases identified 40 days after the last person tested negative and was discharged from care are not unexpected. The WHO recommended criteria for declaring the end of the EVD outbreak includes a 42-day waiting period because undetected chains of transmission or new flare-ups may arise. Findings from the genetic sequencing analysis will be critical to inform the investigation of the source of infection of the new cases and to help detect any missed cases in the chain of transmission that led to the current cluster in Beni Health Zone. It is essential to remain vigilant and maintain appropriate levels of surveillance to rapidly detect and respond to relapse, re-introduction or new emergence events, to implement effective control measures, as well as continue to engage community leaders to address or mitigate community mistrust in affected areas.

::::::
::::::

Emergencies

Emergencies

POLIO
Public Health Emergency of International Concern (PHEIC)

Polio this week as of 22 April 2020
:: The polio eradication programme is making an important contribution to the COVID-19 response across different regions in the world. In a candid statement, Dr. Ahmed Al-Mandhari, Regional Director, WHO EMRO, highlights the programme’s activities in fighting the pandemic in the region. Read more

Summary of new viruses this week (AFP cases and ES positives):
:: Afghanistan: one WPV1 case
:: Pakistan: two WPV1 cases, eight WPV1 positive environmental samples and seven cVDPV2 cases
:: Cameroon: two cVDPV2 cases and one cVDPV2 positive environmental sample
:: Chad: six cVDPV2 cases and two cVDPV2 positive environmental samples

::::::

Breakthrough in the Global Battle Against Polio: AJ Vaccines Granted WHO Prequalification for New Polio Vaccine
International vaccine manufacturer, AJ Vaccines has received WHO prequalification for Picovax®, the first stand-alone dose sparing Inactivated Polio Vaccine (IPV) on 21st April 2020. First deliveries to UN agencies such as UNICEF and PAHO are expected by mid-2020
April 21,2020 COPENHAGEN, Denmark–(BUSINESS WIRE)–Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccines’ dose sparing technology provides a significant opportunity to expand supply, with the potential to deliver up to 100 million doses over the five-year period 2020-2024 to help meet the currently unmet global demand for inactivated polio vaccines…

::::::

WHO Grade 3 Emergencies [to 25 Apr 2020]

Democratic Republic of the Congo
:: Ebola Outbreak in DRC 89: 21 April 2020
[See Ebola above for detail]

Nigeria – No new digest announcements identified
Somalia – No new digest announcements identified
South Sudan – No new digest announcements identified
Syrian Arab Republic – No new digest announcements identified
Yemen – No new digest announcements identified

::::::

WHO Grade 2 Emergencies [to 25 Apr 2020]
Burkina Faso [in French]
:: Riposte contre la pandémie du Covid-19 : La Chine vole au secours du Burkina Faso
25 avril 2020

Niger
:: Le Niger signale une nouvelle épidémie de polio 24 avril 2020

Angola – No new digest announcements identified
Afghanistan – No new digest announcements identified
Burundi – No new digest announcements identified
Cameroon – No new digest announcements identified
Central African Republic – No new digest announcements identified
Ethiopia – No new digest announcements identified
Iran – No new digest announcements identified
Iraq – No new digest announcements identified
Libya – No new digest announcements identified
Malawi – No new digest announcements identified
Measles in Europe – No new digest announcements identified
MERS-CoV – No new digest announcements identified
Myanmar – No new digest announcements identified
occupied Palestinian territory – No new digest announcements identified
Sudan – No new digest announcements identified
Ukraine – No new digest announcements identified
Zimbabwe – No new digest announcements identified

::::::

WHO Grade 1 Emergencies [to 25 Apr 2020]

Kenya
:: Malaria vaccine pilot in Africa one year on: new vaccine could boost Kenya’s malaria…
24 April 2020

Chad – No new digest announcements identified
Djibouti – No new digest announcements identified
Mali – No new digest announcements identified
Namibia – viral hepatitis – No new digest announcements identified
Tanzania – No new digest announcements identified

::::::
::::::

UN OCHA – L3 Emergencies
The UN and its humanitarian partners are currently responding to three ‘L3’ emergencies. This is the global humanitarian system’s classification for the response to the most severe, large-scale humanitarian crises. 
Syrian Arab Republic
:: Syrian Arab Republic: COVID-19 Update No. 07 – 25 April 2020
:: Recent Developments in Northwest Syria Flash Update – As of 24 April 2020

Yemen
:: Yemen: Flash Floods Flash Update No. 2 (As of 23 April 2020)

::::::

UN OCHA – Corporate Emergencies
When the USG/ERC declares a Corporate Emergency Response, all OCHA offices, branches and sections provide their full support to response activities both at HQ and in the field.
CYCLONE IDAI and Kenneth
:: Zimbabwe Situation Report, 21 Apr 2020

HIGHLIGHTS
. The first imported COVID-19 case was reported on 21 March 2020 and local transmission started on 24 March. As of 20 April, 25 COVID-19 cases were confirmed, including three deaths.
. Despite a one-week disruption due to COVID-19 and the lockdown, nearly 3.4 million people received food or cash assistance in March.
. The number of children treated for acute malnutrition has reduced from 952 in January to 741 in February and 354 in March.
. Since the start of the lockdown, national GBV hotlines have recorded a call increase of over 90 per cent. The child helpline received an increase of 43 per cent in the daily calls.
. About 43,350 people remain displaced in four camps and in host communities.

:: EBOLA OUTBREAK IN THE DRC – No new digest announcements identified

::::::
::::::

The Sentinel

Human Rights Action :: Humanitarian Response :: Health :: Education :: Heritage Stewardship ::
Sustainable Development
__________________________________________________
Week ending 18 April 2020 :: Number 313

This weekly digest is intended to aggregate and distill key content from a broad spectrum of practice domains and organization types including key agencies/IGOs, NGOs, governments, academic and research institutions, consortia and collaborations, foundations, and commercial organizations. We also monitor a spectrum of peer-reviewed journals and general media channels. The Sentinel’s geographic scope is global/regional but selected country-level content is included. We recognize that this spectrum/scope yields an indicative and not an exhaustive product. Comments and suggestions should be directed to:

David R. Curry
Editor
GE2P2 Global Foundation – Governance, Evidence, Ethics, Policy, Practice
david.r.curry@ge2p2center.net

PDF:The Sentinel_ period ending 18 Apr 2020

Contents
:: Week in Review  [See selected posts just below]
:: Key Agency/IGO/Governments Watch – Selected Updates from 30+ entities   [see PDF]
:: INGO/Consortia/Joint Initiatives Watch – Media Releases, Major Initiatives, Research:: Foundation/Major Donor Watch -Selected Updates
:: Journal Watch – Key articles and abstracts from 100+ peer-reviewed journals  [see PDF]

Joint Letter to UN Security Council on Participation and Transparency

Governance :: Security Council

Joint Letter to UN Security Council on Participation and Transparency
17 April 2020 – New York
To: The President of the Security Council, H.E. Mr. José Singer Weisinger
Excellency,
We, the undersigned civil society organisations, write to you as human rights, humanitarian, development and peacebuilding organisations that actively and regularly contribute to the work of the UN Security Council. We write to you at this time to raise concerns around the transparency of the work of the Security Council and obstacles to the effective participation of civil society in its work due to recent changes to the working methods of the Council in response to the COVID-19 pandemic.

The agreement by Council members on procedures for its meetings and adoptions during China’s presidency in March was a vital step forward to ensure the work of the Security Council continued in an unprecedented and challenging time. We welcome further efforts by the Dominican Republic, as President of the Council in April, to increase transparency including through the practice of publishing the Informal Plan of VTC of the Security Council, allowing a live webcast of the relevant briefers moderated by the President of the Council during “Open VTCs”, and of striving to publish press elements following Council sessions.

However, there continue to be significant challenges to ensuring transparency and meaningful participation of civil society in the Council’s work. We were disappointed, for example, that it took nearly a month following the WHO’s declaration of a pandemic for the Security Council to invite the Secretary General to brief and that it was decided that the briefing would be held behind closed doors, despite requests from other Member States to keep it open. Civil society access to the Council has also considerably shrunk as a result of the new working methods.

As civil society organisations working on every area on the Security Council’s agenda, we bring dedicated expertise and experience that we believe is vital to complement the work of States and UN agencies, and critical to ensuring a more effective and accountable Security Council. This is particularly crucial as the COVID-19 pandemic affects every person in the world in distinct ways.

As organisations working at global, national and local levels often in partnership with grassroots organisations and with communities affected by many of the situations and issues on the Council’s agenda, it is critical that the voices of those we serve and whose rights we fight for, including women, girls and boys, persons with disabilities, the displaced, and those most marginalised, are elevated and heard at the global level, particularly during these trying times.

We thus urge the Council to implement, urgently and as a minimum standard, the following steps:
:: Find a solution to broadcast Open VTCs live as a matter of urgency.
:: As an interim measure, while a live broadcast is not possible for technical reasons, effectively publish online the statements of all Council members and briefers for all open meetings.
:: Ensure closed meetings are reserved for closed consultations or meetings that would have otherwise been held in private and not used arbitrarily to reduce the transparency or visibility of the Council’s work.
:: Actively invite civil society organisations to brief during Open VTCs, fulfilling the Council’s expressed commitment in line with numerous Resolutions like UNSCR 2242 (2015), and take all necessary steps to enable their safe and meaningful participation while temporary working methods are in place.
:: Actively and meaningfully consult with civil society on any further decisions regarding working methods of the Security Council.

We offer you our full support and cooperation in seeking to address these issues and efforts to increase transparency during your Presidency in the month of April.

Sincerely,
ACT Alliance
Action Against Hunger (ACF)
Amnesty International
CARE International
Center for Civilians in Conflict (CIVIC)
ChildFund
Concern Worldwide US
Global Centre for the Responsibility to Protect (GCR2P)
Global Partnership for the Prevention of Armed Conflict (GPPAC)
Human Rights Watch (HRW)
Humanity & Inclusion (HI)
International Rescue Committee (IRC)
International Service for Human Rights (ISHR)
Jacob Blaustein Institute for the Advancement of Human Rights
Lutheran World Federation
Network for Religious and Traditional Peacemakers
NGO Working Group on Women, Peace and Security
Oxfam
PAX
Physicians for Human Rights (PHR)
Presbyterian Church (USA)
Save the Children
The Global Justice Center (GJC)
Unitarian Universalist Association
United Methodist Women
War Child
Watchlist on Children and Armed Conflict
Women’s Refugee Commission
World Federalist Movement – Institute for Global Policy (WFM-IGP)
World Vision

ICRC: COVID-19: Middle East faces health crisis, socio-economic earthquake

COVID-19 :: Middle East

ICRC: COVID-19: Middle East faces health crisis, socio-economic earthquake
16-04-2020 | Statement
“The Middle East is today facing the twin threats of potential mass virus outbreaks in conflict zones and looming socio-economic upheaval. Both crises could have severe humanitarian consequences.

The COVID-19 pandemic threatens to be a global socio-economic earthquake. It will be felt acutely in the region’s conflict zones, where millions are already coping with little or no healthcare, food, water and electricity, lost livelihoods, rising prices and destroyed infrastructure.

Deep humanitarian needs will worsen and new ones will emerge if the international community doesn’t factor socio-economic aftershocks into our response. Authorities and local responders must be supported now to ensure people’s lives, livelihoods and food security are protected later.

Much-needed public health measures like lockdowns and curfews already make it difficult or impossible for many people to provide for themselves and their families. Small shops are shuttered. Cafes sit empty. Street vendors have lost their passing trade. The switch to online working could see many left behind. Over time, levels of hunger, malnutrition and chronic illness and stress linked to economic problems could soar.

Across the Middle East, many people are already living a hand-to-mouth existence, struggling to survive and rebuild their lives against vast odds. In Syria, seeing children the same age as my own playing in camps is a humbling experience. They are some of the millions of people we help access clean water every day. In Iraq, mothers and widows told me what our support for their small businesses meant to their families. Such support will be more important than ever in the coming months as we face this pandemic together.

With our Red Cross Red Crescent partners, we are doing our best to help the region’s most vulnerable people and bolster efforts to prevent the spread of the virus. In Yemen, our life-saving support to hospitals, clinics and dialysis centers now includes help with their COVID-19 prevention preparations. In Syria and Iraq, we are helping prisons with their anti-infection measures. Water trucking support to camps, displacement shelters and places of detention ensures people have clean water to wash in. Hygiene kits for displaced people and detainees include soap and shampoo.

More broadly, our water and sanitation services, energy provision, food and household distributions and micro-economic initiatives need to continue and increase where possible, reinforcing support to fragile systems and serving basic needs that may be overshadowed in the pandemic. Right now in Yemen, we have teams out on field trips registering people who need aid. Across the region, we want to increase our support in coming months, especially to people who may be particularly affected like low-income workers, women heading households, farmers and people with disabilities.

We’ve changed the way we work to keep staff and the people we help safe, using physical distancing during distributions, wearing protective equipment and changing how certain aid and cash transfers are delivered, for example. We will continue to adapt and to innovate. We will increase our assistance to the people who need it most, working with our Red Cross Red Crescent partners and the tens of thousands of volunteers who go out every day to help their communities across the Middle East, through the pandemic and beyond it.”

.

Examples of ICRC’s COVID-19 response in the Middle East
Syria: Donating hygiene kits for detainees, as well as preventative equipment and materials like disinfectant, gloves, goggles and gowns to central prisons under the Ministry of Interior; preventative measures in the ICRC-Syrian Arab Red Crescent field hospital in Al Hol camp; hygiene kits to reach 750,000 internally displaced people over next three months.

Iraq: Donating protective equipment and materials like disinfectant, gloves, goggles, gowns to health facilities and places of detention across the country. To date, donated to 18 primary health care centres, two hospitals and 15 physical rehabilitation centres, as well as 27 places of detention housing more than 45,000 detainees.

Yemen: Training, preventive information and material distributed to supported hospitals, primary health care centres and dialysis centers, alongside ongoing support to these facilities; public information campaign including audio spots on COVID prevention measures.

Gaza: Donated 20,000 masks and other protective materials to Palestinian Red Crescent Society; supporting authorities’ quarantine efforts with donations of blankets, mattresses and hygiene kits. Supplying infrared thermometers to screen suspected cases and other medical equipment.

Lebanon: Supporting the main COVID-19 testing and treatment facility in country, Rafic Hariri University Hospital, to boost response and bed capacity; working with detaining authorities in Roumieh prison to upgrade facilities and set up isolation block for suspected and confirmed cases.

Jordan: Provided hygiene and protective equipment for places of detention and correctional facilities; cash transfer programmes for Syrian refugees continues with preventative measures.

Iran: The ICRC has donated CHF 500,000 to the Iranian Red Crescent Society, which is leading the response to and providing services in several areas including disinfection of prisons, screening and treatment of patients, public information campaigns and livelihood support to affected vulnerable people.

.

Existing Humanitarian needs and ICRC response in Middle East
:: Half of all medical facilities in Syria and Yemen are not functioning.
:: Three of ICRC’s five biggest humanitarian operations in 2019 were in Middle East – Syria, Yemen and Iraq
:: In these three countries alone, almost 40 million people need humanitarian aid
:: ICRC provides water and sanitation support to authorities across the region – Syria, Yemen, Iraq, Jordan, Gaza and the West Bank and Lebanon
:: ICRC’s provided food assistance to two million people in the Middle East in 2019.

Call for a Coordinated, Equitable, and Human Rights-based Global Response to COVID-19

COVID-19 :: Equity, Human Rights

Call for a Coordinated, Equitable, and Human Rights-based Global Response to COVID-19
World Federation of Public Health Associations
Friday, 17 April 2020
WFPHA has signed Call for Global Action Plan on COVID-19. The undersigned 99 organizations and 40 individuals call upon heads of state and government of G20 countries to ensure a robust, coordinated global response to the coronavirus disease 2019 (COVID-19) pandemic that is humane, equitable, based in the universality of human rights, and meets the needs of countries and people who are most vulnerable and have the fewest resources…

3. Maximize supply and share health resources globally, equitably and based on need
Higher-income countries have insufficient necessary medical supplies and equipment, yet shortfalls in lower-income countries are far greater still, with a lack of personal protective equipment putting large numbers of health workers at preventable risk, and causing countless avoidable COVID-19 patient deaths. We therefore call upon your governments to:
:: Use the full authorities under your law to demand the utmost efforts of manufacturers to maximize
:: Support WHO in developing a global pool of intellectual property rights for technologies for preventing, detecting, controlling, and treating the COVID-19 pandemic, to make the intellectual property needed to manufacture these technologies and secure their regulator approval freely accessible or available through licensing at reasonable and affordable terms, as proposed by the government of Costa Rica
:: Implement your 26 March 2020 commitment to ensure medical supplies are widely available at affordable prices, on an equitable basis, where most needed, and as quickly as possible, through all necessary actions, which may include:
:: Supporting WHO in developing guidelines to determine where supplies and equipment should be distributed based on these principles; supporting WHO in developing a platform to facilitate needs-based, equitable distribution; and adhering to WHO guidelines
:: Agreeing to donate a significant proportion of any procurements of these supplies and equipment available to WHO, for it to distribute equitably, based on need
. Regularly, publicly report on how you are meeting your 26 March 2020 commitment
. For countries past the peak of their epidemics, or with sufficient levels of supplies and equipment,
share not presently needed supplies and equipment based on the same principles of need and
equity

4. Distribute therapies and vaccines equitably, based on need
Once developed, COVID-19 therapies and vaccines for COVID-19 must also be distributed equitably, based on need, and not on where they are manufactured or what country can pay the most. We therefore call upon your governments to:
:: Work with WHO to develop a plan for manufacturing and distributing any COVID-19 vaccines globally, equitably, based on need, and free at the point of use; and commit to following this plan
:: Immediately provide the Coalition for Epidemic Preparedness Innovations the $2 billion it requires to support developing a vaccine
:: Require any vaccines developed with public funding to be available to governments and international organizations at affordable prices…

Signatories at title link above

World Bank Group to Launch New Multi-donor Trust Fund to Help Countries Prepare for Disease Outbreaks

COVID-19:: World Bank Action

World Bank Group to Launch New Multi-donor Trust Fund to Help Countries Prepare for Disease Outbreaks
WASHINGTON, April 17, 2020 —- Given the urgency for stronger global health security and the need to help developing countries get better prepared for disease outbreaks, the World Bank Group is planning to establish a new Health Emergency Preparedness and Response Multi-Donor Fund (HEPRF). This new fund will complement, and be in addition to, the up to $160 billion of financing the World Bank Group will provide over the next 15 months to support COVID-19 measures that will help countries respond to immediate health consequences of the pandemic and bolster economic recovery.

The HEPRF will provide incentives to low-income countries to increase investments in health preparedness and support the immediate COVID-19 response. In doing so, the HEPRF will help to guide critical health security investments now and in years to come. Specifically, the fund will:
:: Provide incentives to IDA-eligible countries to increase investments in preparedness, for example, by offering co-financing grants that encourage the use of their IDA allocations for better health emergency prevention, detection and response.
:: Enable low-income countries to quickly and effectively respond to major disease outbreaks at an early stage, complementary to IDA’s Crisis Response Window. It will also support other countries and territories that do not have access to financing such as IDA countries in arrears and non-creditworthy IBRD countries.

Japan has expressed its intention to become the founding donor of the new Health Emergency Preparedness and Response Multi-Donor Fund, which is now open for contributions from all donor countries. The World Bank and Japan are encouraging other donor countries to make contributions to this fund to help low income countries with the greatest needs prepare for and respond to major disease outbreaks.

“The new Health Emergency Preparedness and Response Multi-Donor Fund will be another tool in the World Bank’s COVID-19 response and longer-term health preparedness agenda to support low-income countries, as well as the most vulnerable communities, including refugees,” said Annette Dixon, Vice President for Human Development at the World Bank. “We are thankful to the Government of Japan for their leadership in health security and encourage other donors to join us.”

As part of the World Bank’s trust fund reform, the new Health Emergency Preparedness and Response Multi-Donor Fund will anchor the Umbrella Program for Health Security. The objective of this umbrella is to help countries develop strong public health capacity, including preparedness, disease surveillance, laboratory and diagnostic capacity, health human resources, as well as emergency response operations.

COVID-19 security measures no excuse for excessive use of force, say UN Special Rapporteurs

COVID-19 :: Freedoms, Force

COVID-19 security measures no excuse for excessive use of force, say UN Special Rapporteurs
GENEVA (17 April 2020) – UN Human rights experts* have expressed grave concern at the multiplication of accounts of police killings and other acts of violence within the context of COVID-19 emergency measures.

“We are alarmed at the rise of reports of killings and other instances of excessive use of force targeting in particular people living in vulnerable situations,” said the Special Rapporteurs.

“Persons in vulnerable situations such as people living in poverty and those living in slums, homeless persons, minorities, individuals in detention, women and children victims of domestic violence, migrants and refugees, trans women and all those who defend their rights, are already affected disproportionately by the virus. No-visitor policies in nursing homes and home care exacerbate the risk of violence, maltreatment, abuse and neglect of older persons and others living in institutions.”

“All these people who are often disproportionately affected by the virus, because of their precarious conditions of existence, should not be victimized further because of state of emergency measures.”

The experts reminded governments and law enforcement agencies that the prohibition against arbitrary deprivation of life, torture and other ill-treatment, is absolute and non-derogable at all times.

“Even during states of emergency, the use of force remains guided by the principles of legality, necessity, proportionality and precaution. They demand that the use of force and of firearms must be avoided, and that all possible non-violent means must be exhausted before resorting to violent ones.”

Law enforcement agencies, the experts recalled, should only use force when strictly necessary. Lethal force should only be used to protect against an imminent risk to life and even then, reasonable precautions must always be taken to prevent loss of life.

“Breaking a curfew, or any restriction on freedom of movement, cannot justify resorting to excessive use of force by the police; under no circumstances should it lead to the use of lethal force.”

The experts insist that further precautions to protect the right to life and dignity should be taken in view of the fact that so many people have no home in which to remain confined, or live in dense and promiscuous conditions, and do not have the means by which to sustain their families under isolation.

“You can’t stay home if you don’t have one. You can’t remain confined if you don’t have what you need to feed your family,” the human rights experts noted. “How do you ‘physically distance’ in an urban slum? How do you eat or drink when you are a daily-wage labourer and need to go out every day to earn the money to do so?”

“In addition, given the high number of reported COVID-19 infections among police officers, police interactions may represent an additional source of risk of infection for populations already in vulnerable situations that must not be disregarded in the deployment and use of police authority.”

The experts called on governments to devise specific measures to mitigate the disproportionate effects that emergency measures may have on groups in vulnerable situations, and to protect them.

“It is important that law enforcement agencies take into account the local context, the needs and vulnerabilities of particular groups of people, and exercise caution when resorting to the use of force to see to it that it is necessary and proportionate,” they said. “For millions of people, emergency measures can be a more direct threat to their life, livelihood, and dignity than even the virus itself. There are other ways to police than force first.”

“We recommend discussion, instruction, consultation and community engagement – as operating principles for the police, when implementing emergency measures. This is what international law demands because it is what protection of human rights in a time of contagion requires,” the experts concluded.

The WHO should be bolstered, not crippled

COVID-19 :: WHO

No Time to Cut World Health Organization Funding, Secretary-General Stresses, as Member States Battle against Vast COVID-19 Impact
14 April 2020 SG/SM/20045
As I said on 8 April:  “The COVID-19 pandemic is one of the most dangerous challenges this world has faced in our lifetime.  It is above all a human crisis with severe health and socioeconomic consequences.  The World Health Organization (WHO), with thousands of its staff, is on the front lines, supporting Member States and their societies, especially the most vulnerable among them, with guidance, training, equipment and concrete life-saving services as they fight the virus.

“It is my belief that the World Health Organization must be supported, as it is absolutely critical to the world’s efforts to win the war against COVID-19.  This virus is unprecedented in our lifetime and requires an unprecedented response.  Obviously, in such conditions, it is possible that the same facts have had different readings by different entities.  Once we have finally turned the page on this epidemic, there must be a time to look back fully to understand how such a disease emerged and spread its devastation so quickly across the globe, and how all those involved reacted to the crisis.  The lessons learned will be essential to effectively address similar challenges, as they may arise in the future.  But, now is not that time.”

As it is not that time, it is also not the time to reduce the resources for the operations of the World Health Organization or any other humanitarian organization in the fight against the virus.

As I have said before, now is the time for unity and for the international community to work together in solidarity to stop this virus and its shattering consequences.

::::::

Financial Times, 16 April 2020
Opinion – Editorial Board
The WHO should be bolstered, not crippled
Suspending US funding to global health body is grossly irresponsible 
A global pandemic demands a global response. The only international body that can provide that response is the World Health Organization. It is the WHO’s job to track the spread of coronavirus, to share information and advice about best practice, and to help co-ordinate the international response to a common threat to humanity. To cut the WHO off at the knees during the biggest global health emergency for a century is, therefore, grossly irresponsible. Yet that is precisely what Donald Trump’s administration has done, by suspending US funding for the WHO.

As it struggles with this pandemic, the WHO needs more money, not less. It is a sorry state of affairs that the Gates Foundation, a private organisation, is the second-largest donor to the WHO, after the US, and that the Rotarians donate considerably more money to the organisation than the People’s Republic of China.

The fact that the Trump administration is behaving recklessly does not mean that the WHO’s behaviour over coronavirus has been beyond reproach. Far from it. On January 14, the WHO tweeted that there was no “clear evidence of human-to-human transmission” of the coronavirus — an incautious piece of reassurance that echoed the line being taken by the Chinese government. On January 30, Tedros Adhanom Ghebreyesus, the WHO’s director-general, praised China for “setting a new standard for outbreak control” — despite the fact that China had intimidated and silenced doctors who had raised the alarm about the pandemic, and initially refused the WHO’s own requests to send observers to Hubei province, where the outbreak began.

Yet weaknesses in the WHO’s response pale in comparison with Mr Trump’s own complacency. As late as February 24, more than a month after the first Covid-19 case had emerged in America, Mr Trump was tweeting that the disease was “very much under control in the US” and urging people to buy into the stock market. The fact that the president is now rounding on the WHO looks like a transparent effort to deflect attention from his own weak response.
Like any UN agency, the WHO needs the support and co-operation of its members. Securing that co-operation is a particularly difficult task when the world’s two most powerful countries — the US and China — are both run by nationalistic presidents, hypersensitive to any slight to their dignity. Mr Tedros’s early praise for China now looks ill-advised. But it was an understandable error, given that the WHO badly needed China’s co-operation.

The real problem was the Chinese government, not the WHO. China’s initial failure to be open about events in Wuhan has been compounded by its obsession with preventing recognition of Taiwan. Yet, despite close links to the mainland, Taiwan has done an admirable job in containing the pandemic and was among the first to warn of human-to-human transmission.
However, if a secretive China exerts excessive influence over the WHO, the answer is not for the US to withdraw. The real solution is for western powers — above all the US and the EU — to work together to improve the organisation. Instead, the Trump administration has treated both the UN and the EU as deeply suspect, belittling and ignoring them. Washington’s neglect and western disunity have allowed the Chinese government greatly to expand its influence within UN agencies.

Restoring US and western influence in those agencies is a key task. But it must wait for calmer times. Right now, the WHO needs to be allowed to get on with its job. The US threat of crippling cuts in its funding must be withdrawn.

More than 117 million children at risk of missing out on measles vaccines, as COVID-19 surges

Milestones :: Perspectives :: Research

COVID-10 :: Impacts

More than 117 million children at risk of missing out on measles vaccines, as COVID-19 surges
Statement by the Measles & Rubella Initiative: American Red Cross, U.S. CDC, UNICEF, UN Foundation and WHO
ATLANTA/GENEVA/NEW YORK, 14 April 2020: “As COVID-19 continues to spread globally, over 117 million children in 37 countries may miss out on receiving life-saving measles vaccine. Measles immunization campaigns in 24 countries have already been delayed; more will be postponed.

“During this challenging period, the Measles & Rubella Initiative (M&RI) expresses solidarity with families, communities, governments and emergency responders and joins our global immunization and health partners, including those within Gavi, the Vaccine Alliance and the Global Polio Eradication Initiative (GPEI) in our collective focus and fight against the threat of COVID-19. The pandemic sweeping the globe requires a coordinated effort and commitment of resources to ensure frontline health workers around the world are protected, as they face and respond to this new threat. At the same time, we must also champion efforts to protect essential immunization services, now and for the future.

“The World Health Organization (WHO) has issued new guidelines endorsed by the Strategic Advisory Group of Experts on Immunization — to help countries to sustain immunization activities during the COVID-19 pandemic. The guidelines recommend that governments temporarily pause preventive immunization campaigns where there is no active outbreak of a vaccine-preventable disease. M&RI partners, which include the American Red Cross, the U.S. Centers for Disease Control and Prevention, UNICEF, the United Nations Foundation and WHO, strongly agree with these recommendations. We also urge countries to continue routine immunization services, while ensuring the safety of communities and health workers. The recommendations also ask governments to undertake a careful risk-benefit analysis when deciding whether to delay vaccination campaigns in response to outbreaks, with the possibility of postponement where risks of COVID-19 transmission are deemed unacceptably high.

“If the difficult choice to pause vaccination is made due to the spread of COVID-19, we urge leaders to intensify efforts to track unvaccinated children, so that the most vulnerable populations can be provided with measles vaccines as soon as it becomes possible to do so. While we know there will be many demands on health systems and frontline workers during and beyond the threat of COVID-19, delivering all immunization services, including measles vaccines, is essential to saving lives that would otherwise be lost to vaccine-preventable diseases.

“The M&RI supports the need to protect communities and health workers from COVID-19 through a pause of mass campaigns, where risks of the disease are high. However, this should not mean that children permanently miss out. Urgent efforts must be taken now at local, national, regional and global levels to prepare to close the immunity gaps that the measles virus will exploit, by ensuring that vaccines are available and that they reach children and vulnerable populations, as quickly as possible, to keep them safe.

“Despite having a safe and effective vaccine for over 50 years, measles cases surged over recent years and claimed more than 140,000 lives in 2018, mostly of children and babies – all of which were preventable. Against this already dangerous backdrop, preventive and responsive measles vaccination campaigns have now been paused or postponed in 24 countries to help avert further spread of COVID-19. Campaigns expected to take place later in 2020 in an additional 13 countries may not be implemented. Together, more than 117 million children in 37 countries, many of whom live in regions with ongoing measles outbreaks, could be impacted by the suspension of scheduled immunization activities. This staggering number does not include the number of infants that may not be vaccinated because of the effect of COVID-19 on routine immunization services.  Children younger than 12 months of age are more likely to die from measles complications, and if the circulation of measles virus is not stopped, their risk of exposure to measles will increase daily.  

“The M&RI salutes the heroism of health and emergency workers across the globe, and we recognize the vital role they play in delivering clear, trusted information, as well as preventive and supportive care within their communities. We must invest in health workers and ensure they are protected from infection and empowered as part of sustainable and functioning primary health systems. They are the first line of defense against global epidemics. We also recognize the role of parents and caregivers in ensuring their children are vaccinated by following physical distancing recommendations in line with national guidance. Finally, we call on countries and local leaders to implement effective communication strategies to engage communities, ensure supply and demand for vaccination remains strong, and help assure a healthy life for every child especially in this challenging time.”

 

EMERGENCIES – Coronavirus [COVID-19]

EMERGENCIES

Coronavirus [COVID-19]
Public Health Emergency of International Concern (PHEIC)

Editor’s Note:
We certainly recognize the velocity of global developments in the COVID-19 pandemic. While we have concentrated the most current key reports just below, COVID-19 announcements, analysis and commentary will be found throughout this issue, in all sections.
Beyond the considerable continuing coverage in the global general media, the WHO’s authoritative guidance is available here:
:: Daily WHO situation reports here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
:: WHO Coronavirus disease (COVID-2019) daily press briefings here: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/media-resources/press-briefings

::::::

Situation report – 88 [WHO]

Novel Coronavirus (COVID-19)
17 April 2020
[Excerpts]
SITUATION IN NUMBERS
Globally
2 074 529 confirmed (82 967)
139 378 deaths (8493)

European Region
1 050 871 confirmed (37 778)
93 480 deaths (4163)

Region of the Americas
743 607 confirmed (36 486)
33 028 deaths (2783)

Western Pacific Region
127 595 confirmed (2024)
5558 deaths (1319)

Eastern Mediterranean Region
115 824 confirmed (4392)
5662 deaths (130)

South-East Asia Region
23 560 confirmed (1770)
1051 deaths (61)

African Region
12 360 confirmed (517)
586 deaths (36)

WHO RISK ASSESSMENT
Global Level – Very High

HIGHLIGHTS
:: No new country/territory/area reported cases of COVID-19 in the past 24 hours.
:: Globally, the number of reported confirmed cases exceeded 2 million.

:: WHO has released public health guidance for social and religious practices and gatherings during Ramadan. The guidance also offers advice to strengthen mental and physical wellbeing as the COVID-19 pandemic continues. The guidance is available here.

:: WHO has released guidance on considerations in adjusting public health and social measures in the context of COVID-19. This document is intended for national authorities and decision makers in countries that have introduced large scale public health and social measures. It offers guidance for adjusting public health and social measures, while managing the risk of a resurgence of cases. The guidance is available here.

:: The Chinese authorities have informed WHO that as cases have declined in China and the strain on the healthcare system has eased, a multisectoral team was established in late March 2020 to perform a comprehensive review of COVID-19 data in Wuhan, Hubei Province. Information from a variety of sources was reviewed, leading to duplicate cases being removed and missed cases added. Following this review, the total number of cases in Wuhan increased by 325 and the total number of deaths increased by 1290.

:: As of 11 April 2020, 167 countries, territories and areas have implemented additional health measures that significantly interfere with international traffic.

::::::
::::::

Emergencies – Ebola – DRC+

Emergencies

Ebola – DRC+
Public Health Emergency of International Concern (PHEIC)

Ebola Outbreak in DRC 88: 14 April 2020
[Excerpts]
Situation Update WHO Health Emergencies Programme Page 2
Two new confirmed cases of Ebola virus disease (EVD) were reported in Beni Health Zone on 10 and 12 April (Figure 1). Both cases passed away in the community after visiting several healthcare facilities. Prior to this, the last person who was confirmed to have EVD in the Democratic Republic of the Congo tested negative twice and was discharged from a treatment centre on 3 March 2020.
Specimens from the two cases were sent to the Institut de Recherche Biomedicale (INRB) in Katwa and Kinshasa for genetic sequencing in order to support surveillance teams in the investigation of the source of infection and to determine whether these two cases were linked to a known chain of transmission. A total of 213 contacts of these cases have been registered, 116 of whom were followed on 12 April 2020, and 90 were vaccinated. On 9 April, two new probable cases were validated.
Active outbreak response activities continue, including retrospective and prospective surveillance, pathogen detection, and clinical management activities in previously affected areas, in addition to alert validation, supporting appropriate care and rapid diagnosis of suspected cases, building partnerships with community members to strengthen investigation of EVD deaths in communities, and strategically transitioning activities.

…Conclusion
The newly confirmed cases in Beni Health Zone 40 days into the 42-day count down period to the end of the outbreak are unfortunate but not unexpected. The WHO criteria for end of the outbreak includes a 42-day period when we expect to identify cases within undetected chains of transmission. Thorough investigation of yet-to-be-identified cases and probable cases should be conducted in order to tackle this new chain of transmission. Outbreak response teams continue to face insecurity in affected areas, which makes the ongoing surveillance and response activities particularly challenging. This development reinforces the importance of continued vigilance and the maintenance of strengthened surveillance activities, rapid detection and response capacities in affected areas. It is also important that response activities for other local and global emergencies, including COVID-19 synergize and enhance, not detract from, EVD surveillance and response efforts.

::::::

Congo Records Five New Ebola Cases, Shelves Declaration of End to Epidemic
Five new Ebola infections have been recorded in eastern Congo since last week in a new flare-up just as the government was about to declare an end to the deadly epidemic, the World Health Organization said on Friday.
By Reuters
New York Times, Africa, Apr 17, 2020

::::::
::::::

Emergencies – POLIO; WHO-OCHA Emergencies

Emergencies

POLIO
Public Health Emergency of International Concern (PHEIC)

Polio this week as of 15 April 2020
:: The GPEI will continue to make available the plans and guidance documents regarding the impact of COVID-19 on polio eradication on this page.

Summary of new viruses this week (AFP cases and ES positives):
:: Afghanistan: eight cVDPV2 positive environmental samples
:: Pakistan: three WPV1 cases and five WPV1 positive environmental samples
:: Niger: one cVDPV2 case
:: Ghana: four cVDPV2 positive environmental samples
:: Malaysia: one cVDPV1 positive environmental sample
:: Côte d’Ivoire: one cVDPV2 positive environmental sample

::::::
::::::

WHO Grade 3 Emergencies [to 18 Apr 2020]

Democratic Republic of the Congo
:: Ebola Outbreak in DRC 88: 14 April 2020
[See Ebola above for detail]

Mozambique
:: World Health Organization: 28 cases of COVID-19 confirmed in Mozambique 14 April 2020

Nigeria – No new digest announcements identified
Somalia – No new digest announcements identified
South Sudan – No new digest announcements identified
Syrian Arab Republic – No new digest announcements identified
Yemen – No new digest announcements identified

::::::

WHO Grade 2 Emergencies [to 18 Apr 2020]
Angola
:: COVID-19 accelerated response caravan begins countrywide operation 17 April 2020

Afghanistan – No new digest announcements identified
Burkina Faso [in French] – No new digest announcements identified
Burundi – No new digest announcements identified
Cameroon – No new digest announcements identified
Central African Republic – No new digest announcements identified
Ethiopia – No new digest announcements identified
HIV in Pakistan – No new digest announcements identified
Iran – No new digest announcements identified
Iraq – No new digest announcements identified
Libya – No new digest announcements identified
Malawi – No new digest announcements identified
Measles in Europe – No new digest announcements identified
MERS-CoV – No new digest announcements identified
Myanmar – No new digest announcements identified
Niger – No new digest announcements identified
occupied Palestinian territory – No new digest announcements identified
Sudan – No new digest announcements identified
Ukraine – No new digest announcements identified
Zimbabwe – No new digest announcements identified

::::::

WHO Grade 1 Emergencies [to 18 Apr 2020]

Chad – No new digest announcements identified
Djibouti – No new digest announcements identified
Kenya – No new digest announcements identified
Mali – No new digest announcements identified
Namibia – viral hepatitis – No new digest announcements identified
Tanzania – No new digest announcements identified

::::::
::::::

UN OCHA – L3 Emergencies
The UN and its humanitarian partners are currently responding to three ‘L3’ emergencies. This is the global humanitarian system’s classification for the response to the most severe, large-scale humanitarian crises. 
Syrian Arab Republic
:: Recent Developments in Northwest Syria – Situation Report No. 12 – As of 17 April 2020
. Immense humanitarian needs remain for people in northwest Syria despite a relatively calm security situation under the current ceasefire. Further scale-up is needed as the COVID-19 pandemic intensifies people’s needs and hampers response efforts. Urgent emergency needs are increasingly being exacerbated by needs associated with those of people in longer-term displacement.
. To date, no cases of COVID-19 have been identified in northwest Syria. Humanitarian response efforts continue to focus on preparedness and response planning to minimise potential impact of COVID-19 on communities and on humanitarian partners.
:: Syrian Arab Republic: COVID-19 Update No. 06 – 17 April 2020
Number of people confirmed by the Ministry of Health (MoH) to have COVID-19: 38 (including two fatalities, five recovered)

Yemen – No new digest announcements identified

::::::

UN OCHA – Corporate Emergencies
When the USG/ERC declares a Corporate Emergency Response, all OCHA offices, branches and sections provide their full support to response activities both at HQ and in the field.
CYCLONE IDAI and Kenneth – No new digest announcements identified
EBOLA OUTBREAK IN THE DRC – No new digest announcements identified

 

::::::
::::::